Both IFNα and IFNβ have anti-dengue activity in cell cultures in vitro and in animal models in vivo. However, previous clinical studies have only examined IFNα levels in the context of either DENV2 or DENV3 infections [10], [11], [21]. The gene discussed is IFNA2; the disease is dengue disease.